Tactile Systems stock climbs after a $0.34 EPS beat
Published on 08/29/2026 at 14:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Tactile Systems Technology, Inc. (US87874P1012) reported $0.34 in earnings per share for the quarter ended August 10, 2026, and revenue of $85.70 million, while the shares last changed hands at $23.16 on August 28, 2026.
The quarter also topped the consensus estimate of $0.14 per share by $0.20, and revenue came in slightly above the $85.52 million forecast.
Margin and valuation
The same source put market capitalization at $524.57 million and volume at 384,116 shares, a useful snapshot for a stock that also carried a consensus rating of Moderate Buy and a price target of $38.40.
Net margin was 7.10% and trailing twelve-month return on equity reached 11.49%, giving investors a profitability frame that sits alongside the earnings beat.
What the company sells
Tactile Medical's core business is home-use pneumatic compression therapy systems for lymphedema and other chronic edema-related conditions. That product mix ties the revenue line to recurring clinical adoption rather than a one-time device sale.
Stock and context
At $23.16 as of August 28, 2026, the shares traded well below the $38.40 consensus target while the market cap stood at $524.57 million.
Company details
Company: Tactile Systems Technology, Inc.
ISIN: US87874P1012
Ticker: TCMD
Exchange: Nasdaq
Price (as of August 28, 2026, 4:00 p.m. ET): $23.16 USD
Market cap: $524.57 million
Sector / Industry: Health Care / Medical Devices
Index membership: Russell 2000
